AI assistant
Sending…
Imunon, Inc. — Director's Dealing 2014
Sep 23, 2014
35124_dirs_2014-09-23_510387b2-f29f-4ee1-8d2e-9cb97d74bc6e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2014-06-20
Reporting Person: Tardugno Michael H (Director, CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-06-20 | Celsion Corporation Common Stock | A | 15000 | — | Acquired | 77521 | Direct |
| 2014-06-20 | Celsion Corporation Common Stock | F | 3000 | $3.50 | Disposed | 74521 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-06-20 | Option to Purchase Celsion Corporation Common Stock | $3.50 | A | 140556 | Acquired | 2024-06-20 | Celsion Corporation Common Stock (140556) | Direct |
Footnotes
F1: Represents the closing price of Celsion Corporation Common Stock on the date of grant.
F2: The option vests in thirds on June 20, 2014, June 20, 2015 and June 20, 2016.
More from Imunon, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
May 4
Regulatory Filings
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Major Shareholding Notification
2026
Feb 18